Fulgent Genetics, Inc. financial data

Symbol
FLGT on Nasdaq
Industry
Services-Medical Laboratories
Location
4399 Santa Anita Ave, El Monte, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Fulgent Diagnostics, Inc. (to 7/15/2016)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 491 % -36.3%
Debt-to-equity 8.74 % +8.16%
Return On Equity -3.78 % +72.2%
Return On Assets -3.48 % +72.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.8M shares +3.03%
Common Stock, Shares, Outstanding 30.8M shares +4.01%
Entity Public Float 326M USD -48.2%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.2M shares +1.51%
Weighted Average Number of Shares Outstanding, Diluted 30.2M shares +1.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 283M USD -1.99%
Cost of Revenue 176M USD -4.6%
Research and Development Expense 48.8M USD +17.8%
Selling and Marketing Expense 36.2M USD -12.6%
General and Administrative Expense 88.1M USD -1%
Operating Income (Loss) -73.9M USD +62.2%
Nonoperating Income (Expense) -1.45M USD -122%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52M USD +70.2%
Income Tax Expense (Benefit) -8.14M USD -805%
Net Income (Loss) Attributable to Parent -42.7M USD +74.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 55.1M USD -43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 69M USD +35%
Other Assets, Current 26.4M USD -18.8%
Assets, Current 354M USD -30.4%
Property, Plant and Equipment, Net 106M USD +26.5%
Operating Lease, Right-of-Use Asset 5.4M USD -50.2%
Intangible Assets, Net (Excluding Goodwill) 135M USD -5.65%
Goodwill 22.1M USD 0%
Other Assets, Noncurrent 33.5M USD -4.13%
Assets 1.22B USD -1.24%
Accounts Payable, Current 18.4M USD +19.6%
Accrued Liabilities, Current 24.3M USD -21%
Contract with Customer, Liability, Current 2.23M USD -22.3%
Liabilities, Current 72.9M USD -0.16%
Deferred Income Tax Liabilities, Net 6.37M USD -20%
Operating Lease, Liability, Noncurrent 4.12M USD -42.4%
Other Liabilities, Noncurrent 6.97M USD -53.8%
Liabilities 90.8M USD -11%
Accumulated Other Comprehensive Income (Loss), Net of Tax -368K USD -131%
Retained Earnings (Accumulated Deficit) 590M USD -6.75%
Stockholders' Equity Attributable to Parent 1.13B USD -0.25%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.13B USD -0.36%
Liabilities and Equity 1.22B USD -1.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.27M USD
Net Cash Provided by (Used in) Financing Activities -2.81M USD -155%
Net Cash Provided by (Used in) Investing Activities -47.2M USD -984%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 33.6M shares +3.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.8M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 55.3M USD -43.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 439K USD
Deferred Tax Assets, Valuation Allowance 22.7M USD +42.8%
Deferred Tax Assets, Gross 53.4M USD +16.9%
Operating Lease, Liability 5.56M USD -49.9%
Depreciation 16.4M USD -6.29%
Payments to Acquire Property, Plant, and Equipment 4.06M USD +99.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -44.3M USD +69.6%
Lessee, Operating Lease, Liability, to be Paid 6.65M USD -45.7%
Property, Plant and Equipment, Gross 157M USD +16.4%
Operating Lease, Liability, Current 1.44M USD -63.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.12M USD -52.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.71M USD -60.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.9%
Deferred Income Tax Expense (Benefit) -557K USD +89.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.09M USD -4.39%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.01M USD -43.3%
Deferred Tax Assets, Operating Loss Carryforwards 11.9M USD -32.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 4.56M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 484K USD -71.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.97M USD +1.53%
Depreciation, Depletion and Amortization 24.9M USD -4.65%
Deferred Tax Assets, Net of Valuation Allowance 30.7M USD +3.1%
Share-based Payment Arrangement, Expense 44.5M USD +3.63%
Interest Expense 498K USD +134%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%